This study demonstrates improved VIX pricing performance using a markov-switching garch model, highlighting the role of regime changes.
We propose a Markov‐switching GARCH framework to describe the VIX series. Unlike previous studies on derivatives pricing, both the conditional mean and conditional variance here are allowed to vary with the market state described by a hidden Markov chain process. This switching framework preserves the good properties, under which we derive the analytical pricing formula for the VIX futures. In addition, to make it feasible in practice, we design a novel analytical algorithm that can efficiently filter out all the unobserved variables in the model. The empirical studies show that adding the Markov‐switching terms can significantly improve the fit of the underlying VIX series and the pricing performance of the VIX futures both in‐ and out‐of‐sample. Our research highlights the importance of incorporating regime switches that can be viewed as an additional risk factor into the model framework.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: